pressing albumin and α-fetoprotein (AFP), while intramuscular injection of AFCL into immunodeficient mice produced AFP-positive tumors with primitive endodermal appearance. Hence, E11.5 mouse AF contains cells that efficiently produce XEN lines. These AF-derived XEN lines do not spontaneously differentiate into embryonic-type cells but are phenotypically stable and have the capacity for extensive expansion. The lack of requirement for reprogramming factors to turn AFderived progenitor cells into stable cell lines capable of massive expansion together with the known ability of ExEn to contribute to embryonic tissue suggests that this cell type may be a candidate for banking for cell therapies.
Introduction
In amniotes, the fetus develops inside an amniotic sac that is filled with amniotic fluid (AF), and both contribute to a stable environment and allow movement of the developing fetus. The fluid also contains several cell types of fetal and perhaps amniotic membrane origin. These cells were previously classified by differences in morphology [Gosden, 1983] , surface phenotype, and differentiation potential [De Coppi et al., 2007; Klein and Fauza, 2011] Key Words Amniotic fluid · Fetal anomalies · Primitive endoderm · Self-renewal
Abstract
The cells present in amniotic fluid (AF) are currently used for prenatal diagnosis of fetal anomalies but are also a potential source of cells for cell therapy. To better characterize putative progenitor cell populations present in AF, we used culture conditions that support self-renewal to determine if these promoted the generation of stable cell lines from AFderived cells (AFC). Cells isolated from E11.5 mouse were cultured on irradiated STO fibroblast feeder layers in human embryonic germ cell derivation conditions. The cultures grew multicellular epithelial colonies that could be repropagated from single cells. Reverse transcription semiquantitative polymerase chain reaction of established cell lines revealed that they belonged to the extraembryonic endoderm (ExEn) expressing high levels of Gata6 , Gata4 , Sox17 , Foxa2 and Sox7 mRNA. Hierarchical clustering based on the whole transcriptome expression profile of the AFC lines (AFCL) shows significant correlation between transcription profiles of AFCL and blastocyst-derived XEN, an ExEn cell line. In vitro differentiation of AFCL results in the generation of cells ex-and are also considered to be of potential clinical significance for cell therapy of several types of congenital tissue defects [Kunisaki et al., 2007; Steigman et al., 2009; Gray et al., 2012] To characterize the progenitor potential of cell populations from AF, it is necessary to achieve ex vivo expansion of relatively homogenous cell populations. Previously, this was accomplished using several methodologies, including protocols for culture of mesenchymal stem cells (MSC) [Kaviani et al., 2003; Klein and Fauza, 2011] , expansion protocols used for clinical cytogenetics [De Coppi et al., 2007] , or a combination of an MSC derivation protocol followed by culture in serum-free media for human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) [Moschidou et al., 2013] . These approaches establish multipotent populations of cells with limited self-renewal ability, further described as either MSC [Klein and Fauza, 2011] or c-KIT+ AF-derived stem cells (AFSC) with ability to initiate adipogenic, osteogenic, myogenic, endothelial, neuronal, and hepatic differentiation in vitro [De Coppi et al., 2007; Moschidou et al., 2012] . Using an alternative approach, we sought to establish stable c-KIT+ cell lines with self-renewal capacity by explanting mouse AF-derived cells (AFC) in embryonic germ cell (EGC) derivation conditions, previously used to establish stable cell lines from c-KIT+ primordial germ cells [Shamblott et al., 1998 ].
Explantation has been used to generate different types of self-renewing cell lines [Jaenisch and Young, 2008] , including ESC from different species [Evans and Kaufman, 1981; Martin, 1981; Thomson et al., 1995 Thomson et al., , 1996 Thomson et al., , 1998 ], mouse epiblast stem cells [Brons et al., 2007; Tesar et al., 2007] , and mouse [Matsui et al., 1992; Resnick et al., 1992] and human EGC [Shamblott et al., 1998 ], and it is also an important step in the culture of iPSC [Takahashi et al., 2007] . During explantation, primary progenitor cells are cultured in conditions that support and stimulate self-renewal, typically through the addition of growth factors such as mouse recombinant leukemia inhibitory factor (LIF) and/or human recombinant basic fibroblast growth factor (FGF-2), mitotically inactivated mouse embryonic fibroblasts (MEF), and specially screened lots of fetal bovine serum (FBS) or commercial serum replacer until stable cell lines are successfully generated. In addition to its usefulness in the generation of pluripotent stem cell lines, explantation can also be used to derive lineage-committed permanent cell lines such as extraembryonic endoderm (ExEn) cell lines (XEN) [Kunath et al., 2005; Brown et al., 2010] and trophoblast cell lines [Tanaka et al., 1998] .
In this report, we describe the successful derivation of self-renewing cell lines from E11.5 mouse AF using EGCtype explantation [Shamblott et al., 1998 ]. In addition, we show that these cell lines have the phenotypic and gene expression profiles most similar to blastocyst-derived XEN cells, and we demonstrate their in vitro and in vivo primitive endoderm (PrE) lineage differentiation potential.
Materials and Methods

AF Cell Line Generation and Culture
Cell lines were derived from mouse strain 129X1/SvJ (Jackson Laboratory). Mouse AF was obtained from dissected intact E11.5 amniotic sacs through micropuncture. The collected cells were filtered using a 40-μm cell strainer (BD Biosciences) followed by a single washing step in high-glucose DMEM (Hyclone) with 10% FBS (Sigma). Cells isolated from 5 amniotic sacs were plated into a single well of a tissue culture-treated 12-well plate containing irradiated STO feeders (56-X; ATCC) at a density of 110,000 cells/ cm 2 . The plating media consisted of knockout DMEM/F12 (Gibco) with 15% of ESC-screened FBS (Sigma), 0.1 m M nonessential amino acids, 2 m M glutamine, 1 m M sodium pyruvate (Gibco), 1× EmbryoMax nucleosides (Millipore), 0.14 m M 2-mercaptoethanol (Sigma), 1,000 U/ml ESGRO (Millipore), 2 ng/ml FGF-2 (Invitrogen), 10 μ M forskolin (Sigma), and 25 ng/ml mouse recombinant stem cell factor (SCF; R&D Systems). During the first 4 passages, culture splitting was performed every 8-9 days using 0.25% trypsin EDTA solution followed by vigorous pipetting to obtain a singlecell suspension. Upon the appearance of the first colonies ( ∼ 4 weeks), the culture of AFC lines (AFCL) was continued using mitomycin C-treated MEF feeder cells, strain CF-1 (Millipore), in the absence of forskolin or SCF. During routine culture, established cell lines were grown to subconfluence and passaged every 3-4 days using 0.05% trypsin EDTA or TrypLE Express solution (Invitrogen) . We cryopreserved cells in freezing media containing 10% DMSO (Acros Organics). Mouse ESC (CCE line) were cultured using standard methods (ATCC). The XEN10 cell line, a kind gift from Drs. A.C. Foley and A.K. Hadjantonakis, was cultured as described by Brown et al. [2010] .
Abbreviations used in this paper
Doubling-Time Analysis
For this analysis, cells of each AFCL were initially plated at 15,625 cells/cm 2 in a gelatinized 6-well plate preseeded with 20,000 cells/cm 2 of irradiated CF-1 fibroblasts in a regular AFCL growth medium. Upon reaching 80-90% confluence, each AFCL was replated in triplicate at 15,625 cells/cm 2 in gelatinized wells of a 6-well plate preseeded with the above-described number of irradiated CF-1 fibroblasts. After 46 h, cells were treated with TrypLE Express solution and live cells were counted. The counts were normalized for the numbers of remaining irradiated CF-1 fibroblasts. The doubling time (DT) was calculated as previously described [Moschidou et al., 2012] : DT = t/[log 2 (y/m)], where t = time in culture, y = number of cells at the end of the culture, and m = number of cells at the beginning of the culture.
Semiquantitative Polymerase Chain Reaction
Total RNA extraction was performed using an RNeasy Plus Mini kit (Qiagen) followed by reverse transcription with a QuantiTect reverse transcription kit (Qiagen) using 500 ng of total RNA in each reaction. Real-time polymerase chain reaction (PCR) was performed on 1/20 of the reverse transcription reaction volume as a template using the Power SYBR Green PCR Master Mix (Applied Biosystems). The primers for the Gata6, Gata4, Pou5f1, Sox2, Nanog, Sox7, Sox17, Sall4, Lin28a , and Alb were synthesized by Sigma-Aldrich based on sequences suggested by the Primer Express 3.0 software (Applied Biosystems). Primers for mouse 18s RNA, Afp, Foxa2 and Utf1 were manufactured by Qiagen. Samples were analyzed using the Applied Biosystems StepOne real-time PCR instrument. We analyzed results using one-way ANOVA followed by Tukey's multiple comparison test functions by GraphPad Prism software. For the list of primer sequences and cycling conditions, see online supplementary table S1 (for all online supplementary material, see www. karger.com/doi/10.1159/000353942).
Immunostaining of Cultured Cells
We stained cells cultured in a 4-well CultureSlide (BD Falcon) coated with 0.1% gelatin solution (Millipore) for 1 h at room temperature, using SALL4, UTF1, LIN28, GATA6, and FOXA2 antibodies at the following dilutions: SALL4 1: 200 (ab29112; Abcam), UTF1 1: 300 (ab24273; Abcam), LIN28 1: 300 (ab63740; Abcam), GATA6 1: 200 (ab22600; Abcam), and FOXA2 1: 300 (sc-6554; Santa Cruz Biotech). Cells cultured on collagen I-coated 4-well CultureSlide were stained for α-fetoprotein (AFP) and albumin (ALB) as described previously [Gouon-Evans et al., 2006] . For all other antibodies, cells were fixed with 4% methanol-free formaldehyde for 10 min at room temperature and then washed three times with phosphate-buffered saline (PBS) followed by permeabilization with 0.2% Triton X-100 in PBS for 5 min (ALB and AFP) or 10 min (SALL4, UTF1, GATA6, and FOXA2). No additional permeabilization was performed for LIN28 staining. After 3 washes in PBS, the cells were blocked for 2 h at room temperature in PBS containing 5% milk, 10% normal goat serum (Jackson ImmunoResearch) and 0.1% Tween 20 (Sigma-Aldrich). Subsequently, cells were stained overnight at 4 ° C with primary antibody or rabbit IgG (Santa Cruz Biotech) diluted in blocking buffer. The next day, cells were washed 3 times with PBS and stained for 1 h at room temperature with Alexa488-conjugated secondary antibody (1: 200, Invitrogen). At the end of the staining period, cells were washed in PBS 3 times and counterstained with DAPI (Invitrogen) for 30 min. Staining was visualized using either a Zeiss LSM 510 confocal system (UTF1, LIN28, and FOXA2), DeltaVision deconvolution microscope (SALL4, ALB, and AFP), or Nikon A1 confocal microscope (GATA6). We used ImageJ software (National Institutes of Health) for all image processing.
Tumor Formation Assay and Tissue Immunohistochemistry
The in vivo lineage potency of generated cell lines was assessed by intramuscular injection of 1 × 10 6 AFCL or 0.5 × 10 6 ESC (CCE, positive control) into the upper hind limb of NOD-SCID IL2Rγ null immunodeficient mice (Jackson Laboratory), and teratoma/tumor formation was monitored for 3 months. Collected tumors were fixed in 25% formalin and processed by the Pathology Core of the Dana-Farber/Harvard Cancer Center. Paraffin-embedded tissue was processed for AFP staining as described (R&D Systems) except that the antigen retrieval step was performed for 45 min at 95 ° C using pH 9 antigen retrieval solution (DAKO). Primary antibody against AFP (Ab-2, Neomarkers) was used at 1: 100 dilution. Chromogenic detection of bound antibody was performed using an anti-rabbit HRP-DAB cell and tissue staining kit (R&D Systems).
In vitro Differentiation
AFCL were grown to near confluence in DMEM/F12 (Invitrogen) media containing 15% FBS and 5 ng/ml FGF-2 (R&D Systems). Culture was performed on 0.1% gelatin-coated tissue culture plates containing mitotically inactivated CF-1 feeders at 35,000/cm 2 . The differentiation assay was initiated on day 0 by plating ∼ 1,000 cells/cm 2 on collagen I-coated 6-well plates or 4-well CultureSlide in stage I serum-free media containing DMEM/ F12, 1× N2 and B27 supplements (Invitrogen), 20 ng/ml human activin A, 20 ng/ml mouse recombinant bone morphogenic protein 4 (BMP4), 10 ng/ml FGF-2 (all from R&D Systems), 0.45 μ M monothioglycerol (Sigma), and 50 μ M ascorbic-acid-2-phosphate (Sigma). On day 2, stage II of differentiation was initiated by changing the media to serum-free basic media, as described above, except that the growth factor combination used was mouse BMP4 (20 ng/ml), mouse recombinant epidermal growth factor (20 ng/ ml; R&D Systems), and FGF-2 (10 ng/ml). After 14 days, cells were either submitted to immunofluorescent analysis of AFP and ALB expression or to RNA extraction followed by semiquantitative PCR (qPCR) analysis, as described above.
Microarray Analysis
For microarray analysis, each AFCL was cultured to subconfluence. Subsequently, cells were trypsinized with TrypLE Express solution and submitted to high-speed sorting using a DAKO-Cytomation MoFlo high-speed sorter; the c-KIT+ platelet-derived growth factor receptor-α (PDGFRA+) DAPI-cell population was sorted from each cell line in triplicate. Mouse ESC, CCE line, were submitted to the MEF removal step by allowing suspensions of trypsinized cells to attach to a gelatinized tissue culture dish for 45 min. Subsequently, nonattached cells were gently removed and submitted to RNA extraction. Total RNA from each sample was isolated using an RNeasy Plus Mini kit and subsequently analyzed by the Microarray Core at the University of Texas Health Science Center at Houston. Briefly, 300 ng of total RNA were amplified and purified using an Illumina TotalPrep RNA amplification kit (Ambion). An aliquot of 1.5 μg of amplified products was loaded onto Illumina Sentrix Beadchip Array mouse WG6.V2 arrays, hybridized at 58 ° C in an Illumina hybridization oven for 17 h, washed, and incubated with streptavidin-Cy3 to detect biotin-labeled cRNA on the arrays. Arrays were dried and scanned with BeadArray Reader (Illumina). Microarray data were further analyzed as follows. The data were processed using the Lowess normalization algorithm. After normalization, additional processing was performed using a batch effect removal algorithm [Johnson et al., 2007] based on empirical Bayes methods. All arrays were adjusted so that they have similar distribution. To improve the outcome of the batch effect removal algorithm, all samples processed together with Xen10, Pys2, End2 and ESC samples were used as input. The intensities of all 45,281 probes were included in the calculation of R 2 . Hierarchical clustering was performed using the 'complete' algorithm and 1 -R 2 as a metric. Heatmap tables were generated using the detection p value of 0.01 as a threshold. In case of multiple probes for the same gene, the probe with the highest intensity was reported. The Venn diagram analysis was based on genes whose probes were detected in all biological replicates. A detection p value of 0.01 was used.
Flow-Cytometric Analysis of Surface Marker Expression and Cell Cycle
Monolayer cultures of AFCL were dissociated using TrypLE Express (5 min). Subsequently, isolated cells were stained with directly conjugated antibodies to c-KIT (catalog No. 561074, BD Biosciences) and PDGFRA (catalog No. 562776, BD Biosciences), or c-KIT and C-X-C chemokine receptor type 4 (CXCR4; catalog No. 558644, BD Biosciences) in staining buffer (HBSS + 2% FBS) for 30 min followed by a single washing step. DAPI nuclear staining was used to exclude dead cells. Negative gates were established using isotype controls (catalog Nos. 551139 and 555844, BD Biosciences). Cell cycle analysis was performed as previously described [Mullen, 2004] . Stained cells were analyzed using BD FACSCalibur, LSRII and FlowJo software (Tree Star).
Single-Cell Colony Formation Assay
AFCL and ESC (CCE) were both cultured in the DMEM/F12-based media containing 15% ESC-screened FBS with 1,000 U/ml ESGRO, until 60-70% confluence. To avoid sorting of feeder cells, AFCL were stained for flow cytometry using fluorophore-conjugated antibodies against c-KIT and PDGFRA (1: 100) and CCE were stained with primary fluorescently labeled antibodies for SSEA-1 (catalog No. 560142, BD Biosciences) and EPCAM (catalog No. 17-5791, eBioscience; 1: 100), utilizing the above-described flow-cytometric protocol. Double-positive live cells were sorted as single cell/well into 96-well gelatinized flat-bottom tissue culturetreated plates (BD Falcon) containing previously seeded irradiated CF-1 fibroblasts (R&D Systems) using a DAKO-Cytomation MoFlo high-speed sorter. Three plates were used for each cell line tested. For the secondary sorting experiment, 3 individual wells from 96-well plates, containing colonies, were expanded separately as subcloned cell lines in the original culture conditions for 7 days. Subsequently, the cells from each subclone were single-cell sorted into three 96-well plates each. All secondary plates were examined for colony formation after 7 days of culture. Statistical analysis and data plotting was performed using one-way ANOVA followed by Tukey's multiple comparison test in GraphPad Prism software.
Electron Microscopy
Sample preparation and imaging was performed by the MD Anderson Cancer Center Electron Microscopy Core Facility as follows: samples were treated with a fixative containing 2% glutaraldehyde in 0.1 M PBS, pH 7.3, at 4 ° C overnight and then washed with 0.1 M PBS buffer, pH 7.3, 3 × 10 min. The samples were postfixed with 1% PBS-buffered osmium tetroxide for 1 h, washed with 0.1 M PBS, 3 × 10 min, followed by rinsing with distilled water, 2 × 10 min. Dehydration was performed with increasing concentrations of ethanol for 5 min each followed by treatment with hexamethyldisilazane and air drying overnight. Samples were mounted onto double-stick carbon tabs (Ted Pella) followed by coating under vacuum. Subsequently, platinum coating was performed under vacuum (thickness: 25 nm) followed by carbon coating. Imaging was performed using a JSM-5910 scanning electron microscope (JEOL) at an accelerating voltage of 5 kV.
Results
Irradiated STO Cells Are Required for the Generation of c-KIT+ AFCL
To initiate the EGC-type explantation protocol, we plated AFC on irradiated STO feeder cells in serum containing media in the presence of LIF, FGF-2, SCF, and forskolin. After 3-4 weeks in culture, we noted the first appearance of epithelial colonies ( fig. 1 a) . Using these conditions, we reproducibly generated 3 stem cell lines from 129X1/SvJ mice. These cell lines were termed K82, K83, and K84, in chronological order. Importantly, when AFC were cultured on mitotically inactivated CF-1 fibroblast feeder cells plated at densities varying from 25,000 to 45,000 per cm 2 , using the above-described seeding and splitting protocol and media combination (including LIF, FGF-2, SCF, and forskolin), no observable colony formation occurred after 6 weeks of culture.
To assess the phenotypic stability of the above cell lines, we maintained each in culture for 20 passages over 10 weeks. All 3 cell lines had stable morphology, viabil-ity (data not shown), and growth characteristics (online suppl. fig. S1 and surface phenotype fig. S2 and S3) .
A hallmark of self-renewal is the potential of cells to regenerate colonies from a single cell, so we used a highspeed cell sorter to deposit individual double-positive (CD117 and CD140a for AFCL or SSEA-1 and CD326 for ESC) live cells in each well of a 96-well plate previously seeded with fibroblast feeder cells. The results suggest that all AFCL have the capacity for clonal growth ( fig. 1 b) . Importantly, the efficiency of single-cell sorting, calculated as the percent positive wells, from each AFCL is at least similar or higher (K82) compared to ESC. The maintenance of the self-renewal phenotype is further confirmed through retention of a single-cell cloning efficiency of cells from each of the 3 previously sorted individual clonal lines of K84 parent cell line ( fig. 1 b, dark  bars) .
We determined the ploidy of cultured AFCL by flowcytometric cell cycle analysis, which showed that 25-32% of the cells are diploid in G1 phase, 49-51% are in S phase, and 13-19% are in G2 phase of the cell cycle; about 5% of cells had intermediate DNA content. A representative propidium iodide staining of K83 cells is shown in figure  1 c. In addition, analysis of growth kinetics of exponen- fig. S1 ).
Morphology and Surface Phenotype of AFCL Is Similar to Blastocyst-Derived ExEn Stem Cell Lines
The initial appearance of AFCL was characterized by epithelial colony formation. These colonies are nested inbetween MEF feeders ( fig. 1 a) . When the AFCL are grown on a gelatin-coated surface in the absence of feeder cells, however, they assume several different morphologies, including rounded cells and epithelial sheets, similar to the previously described morphologies of cultured XEN [Kunath et al., 2005] (online suppl. fig. S4 ). Scanning electron microscopic examination of AFCL grown on gelatincoated surfaces showed the presence of rounded cells rich in microvilli, also similar to previously described XEN cells [Kunath et al., 2005] ( fig. 1 d) .
To evaluate phenotypic similarities between AFCL and XEN, we performed flow-cytometric analysis of the surface phenotype of AFCL and XEN10 using a panel of antibodies against surface markers previously shown to be expressed on either AF-derived progenitors (c-KIT) [De Coppi et al., 2007; Moschidou et al., 2012] [Takakura et al., 1997; Plusa et al., 2008; Artus et al., 2010] . As shown in figure 2 , both AFCL ( fig. 2 b) and XEN ( fig. 2 d) are c-KIT and PDGFRA double positive. At the same time, both cell types are mostly negative for CXCR4 expression ( fig. 2 a, c) , consistent with the assignment of E11.5-derived AFCL to the XEN lineage. In addition, fluorescence-activated cell sorting (FACS) of the above-mentioned marker expression in early-(online suppl. fig. S2 ) and late-passage AFCL (online suppl. fig. S3 ) confirms their phenotypic stability over multiple passages.
Analysis of the Gene Expression Profile of AFCL Confirms That They Belong to the Family of ExEn Stem Cells
To analyze the gene expression pattern potentially associated with self-renewal of AFCL in culture, we initially examined mRNA expression of 6 genes that are notably involved in self-renewal of ESC, including: Pou5f1 , Nanog , Sox2 , Lin28a , Utf1 , and Sall4 . Our results showed that both AFCL and XEN10 express levels of Lin28a , Utf1 , and Sall4 mRNA comparable to those expressed in ESC ( fig. 3 a) . To verify the corresponding protein expression, we used immunofluorescence analysis of cultured AFCL-K83 stained with LIN28, UTF1, and SALL4 antibodies, and showed that K83 cells express significant levels of the 3 proteins ( fig. 3 b-d) . Because self-renewal of XEN cells is dependent on Sall4 expression [Lim et al., 2008] , we hypothesize that Sall4 expression has a similar importance in AFCL self-renewal, while the specific roles of Lin28 and Utf1 remain to be tested. Importantly, neither AFCL nor XEN express significant levels of the 3 key pluripotency-related genes, Pou5f1 , Sox2 , and Nanog , suggesting that AFCL, like XEN, exist in a lineage-committed self-renewal state.
While both PrE and DE share a significant overlap in gene expression patterns, including Gata4 , Gata6 , Sox17 , and Foxa2 , the cells of PrE also express Sox7 [Seguin et al., 2008] . We therefore compared the expression of Gata4 , Gata6 , Foxa2 , Sox17 , and Sox7 mRNA in ESC, XEN, and AFCL. As shown in figure 4 a, AFCL-K83 express similar levels of PrE lineage genes as XEN cells. In addition, comparative qPCR analysis of Gata6 , Gata4 , Sox7, and Sox17 in all 3 AFCL suggests similar expression levels of the 4 PrE-related genes (online suppl. fig. S5A ), except that in this experiment K82 appears to have somewhat higher expression of Gata6 compared with K83 and K84. Protein expression and localization of GATA6 and FOXA2 transcription factors in K83 cells were also confirmed using immunofluorescent analysis of cells grown on culture slides ( fig. 4 b, c) .
Because previous studies support a XEN lineage potential for AFCL, we performed an Illumina mouse whole-genome 6.0 BeadChip-based microarray gene expression analysis on AFCL and compared the obtained data with the gene expression profile of mouse ESC and a previously published microarray data set of three different ExEn-like cell lines [Brown et al., 2010] . Hierarchical clustering of AFCLs, ESC, and ExEn-like cell lines reveals that the whole transcriptome profile of AFCLs is most closely related to blastocyst-derived XEN cells, followed by Pys2 line, while it is well separated from the expression profiles of End2 line and ESC ( fig. 5 a) . To examine additional similarities and differences between AFCL, XEN, and ESC, we plotted Venn diagrams depicting the number of common and unique genes between the 3 types of cell lines and we observed that the number of common genes between AFCL and XEN is 7,952, compared with the number of commonly expressed genes between AFCL and ESC of 7,042 and between XEN and ESC of 7,131, confirming a closer relationship between AFCL and XEN than between AFCL and ESC ( fig. 5 b) , as suggested by the dendrogram. To more precisely characterize the endodermal potential of AFCL, we examined the expression of genes related to different endodermal subtypes by making a comparative expression heatmap of genes previously shown to be characteristic for various endodermal subtypes, including VE, regional VE, DE, PE, and PrE [Yasunaga et al., 2005; Brown et al., 2010] ( fig. 6 ). These results suggest that all 3 cell lines express a number of markers for PrE, PE, and VE. More specifically, there is a moderate expression of Thbd and Gata4 in K82 compared with K84 cells, and an intermediate level of these 2 genes in K83. All 3 cell lines also express most of the listed markers of VE and regional VE (excluding Tmprss2 and Amn ) with slightly lower levels of Ttr , Hnf4a , Foxa3 , Fxyd3, and Hhex in K84 compared with K82, while K83 does not express Foxa3 and Dkk1 . However, the significance of these minor variations in endodermal lineage gene expression is not clear at this time. AFCL also have a notable absence of Cxcr4 , a previously described DE marker [Yasunaga et al., 2005] , which correlates well with FACS analysis of comparative surface marker expression ( fig. 2 ; online suppl. fig. S2, S3 ). In summary, AFCL display significant levels of expression of PrE-related genes and more specifically genes related to both PE and VE, with some variation in 
In vitro Differentiation of AFCL Cells Results in the Generation of AFP-and ALB-Producing Cells
To examine the potential for in vitro endodermal lineage commitment of AFCL, we treated these cells with several different cytokines, including BMP4, activin A, epidermal and hepatocyte growth factor, FGF-2, and FGF-4, individually and in combination, followed by measurement of mRNA and protein expression of AFP and ALB as markers of maturing embryonic and ExEn lineages. The most efficient differentiation protocol was based on a previously published study [Yasunaga et al., 2005] and it required the presence of BMP4 during both fig. 7 b) , consistent with the known role of BMP4 in differentiation of blastocyst-derived XEN into AFP-expressing VE [Artus et al., 2012; Paca et al., 2012] . Comparative qPCR analysis of Afp and Alb expression before and after differentiation in all 3 AFCL is shown in online supplementary figure S5B . These results confirm that all 3 AFCL are capable of in vitro differentiation in the presence of BMP4. In addition, it can also be noted that K82 has a slightly higher efficiency of differentiation (suggested by the difference in Afp and Alb levels between the undifferentiated and differentiated state) compared with the other 2 cell lines, which did not reach the level of statistical significance (online suppl. fig. S5B ).
AFCL Generate PrE Tumors in vivo
The teratoma formation assay is a standard assay for the multilineage potential of pluripotent cells in vivo. We therefore injected cells from either AFCL or ESC (positive control) intramuscularly into immunodeficient mice and observed teratoma formation in the animals. ESCderived tumors appeared after approximately 3 weeks, but AFCL-derived tumors required 6-8 weeks to appear. Histological analysis confirmed the multilineage properties of the control ESC-derived teratoma (data not shown). AFCL-derived tumors, however, had a significantly different appearance from the ESC-derived tumors, with a glandular appearance ( fig. 8 ) and a significant amount of interglandular amorphous matrix, suggestive of an immature endodermal lineage origin. AFCL tumor cells also expressed significant levels of AFP ( fig. 8 b) . Detailed histological examination of AFCL tumors did not yield any evidence of definitive ectodermal, mesodermal, or endodermal differentiation. Hence, AFC likely represent PrE progenitors with limited potential for in vivo PrE differentiation during heterotopic transplantation.
Discussion
Development of cell replacement therapy for degenerative diseases is one of the most eagerly sought goals of stem cell research. A requirement for this goal is the generation of pure populations of progenitor cells with extensive ability for expansion. While differentiation of ESC into lineage-committed cells could fulfill the criteria for clinical application, the requirement for embryo destruction to generate new ESC lines raises substantial ethical and religious barriers to implementation. iPSC are an alternative source of pluripotent cells for lineage differentiation [Takahashi et al., 2007] . Although these cells avoid many of the ethical and availability drawbacks associated with the use of ESC, concerns exist about their true therapeutic value due to the presence of oncogenic viruses and proteins used to immortalize the cells, the low efficiency of iPSC line generation [Sun et al., 2010] , and their limited and unpredictable differentiation potential [Feng et al., 2010] . We therefore determined whether AF could 12-14.6
Normalized intensity Fig. 6 . Heat map of genes characteristic for different endodermal subtypes. Normalized data from the Illumina microarray for genes previously described as specifically expressed in each endodermal subtype. Intensity value was depicted as zero if the p value detected was >0.01. be an alternative source of committed progenitor cells able to give rise to stable self-renewing cell lines that could be used in subsequent cell therapies.
AF contains several types of stem cells, including MSCs and c-KIT+ AFSC. Human AF-derived MSCs have been consistently isolated from AF and have been previously well characterized as positive for surface expression of CD73, CD105, CD44, CD29, CD90, CD13, CD10, CD71, and several other markers [Klein and Fauza, 2011] . These cells are capable of chondrogenic [Kunisaki et al., 2006] and osteogenic differentiation. However, wider application of MSC in regenerative medicine applications may be limited by their finite life span and eventual loss of their stem cell properties during prolonged culture [Liu et al., 2009] . Alternatively, we considered c-KIT+ cells an appropriate candidate for our studies since c-KIT+ AFC have previously been described as capable of limited self-renewal and multilineage differentiation [De Coppi et al., 2007; Moschidou et al., 2012] . As the generation of a stable cell line from progenitor cells likely involves overcoming of a significant epigenetic barrier [Surani et al., 2007] , we hypothesized that the culture conditions previously shown to convert c-KIT+ primordial germ cells to self-renewing c-KIT+ EGC lines may also facilitate such conversion of AFC [Matsui et al., 1992; Resnick et al., 1992; Shamblott et al., 1998 ].
An important aspect of the generation of stem cell lines in vitro is maintenance of cultured cells in an in vitro 'niche' environment [Davey and Zandstra, 2006] . To establish the key components of the initial AFCL culture that stimulated cell line formation, we varied several culture parameters, including growth factor composition and feeder cell type. The resulting conclusion is that utilization of irradiated STO cells is critical for achieving reproducible success in cell line generation. Application of commonly used CF-1 feeder cells was unsuccessful, resulted in a gradual decrease in the total cell number in culture, and subsequent failure to establish stable cell lines. The exact mechanism of benefit from STO cells is not clear, but it is likely related to differences in the amount and the type of cytokines and/or extracellular signaling molecules, including activin A (high in CF-1), hepatocyte growth factor (high in STO), IL-6 (high in CF-1), SCF (high in STO), and others [Talbot et al., 2012] . Since AFCL are consistently c-KIT+ and fail to be generated on CF-1 cells, it is possible that c-KIT-SCF interaction is critical for AFCL generation. However, because we used an identical derivation medium (containing exogenous soluble SCF) with either STO or CF-1 feeders, we hypothesize that it is the transmembrane SCF that may play an important role in AFCL derivation based on previously shown differential effects of soluble and transmembrane SCF in other cell types [Ashman, 1999] . Importantly, comparison of derivation conditions for blastocyst-derived XEN cells [Kunath et al., 2005] and our results with AFCL suggests that the more advanced developmental stage of AFCL require more elaborate culture conditions for cell line generation, as blastocyst-derived XEN can be successfully generated even on mitotically inactivated primary fibroblast feeders.
Self-renewal is one of the two key properties of stemness. The most detailed studies of stem cell self-renewal mechanisms have been performed in the ESC system where a core self-renewal machinery was described consisting of Pou5f1, Sox2, and Nanog genes [Boyer et al., 2005; Mallanna and Rizzino, 2012] . The proteins coded by the 3 genes maintain self-renewal through regulation of a large transcriptional network that includes targets such as Sall4 [Lim et al., 2008] , Lin28 [Shyh-Chang and Daley, 2013] , Utf1 [Laskowski and Knoepfler, 2012] , and others. To examine the genes potentially involved in selfrenewal of AFCL, we analyzed the expression of the above-mentioned genes and discovered that the self-renewal of AFCL, like XEN, can be maintained in the absence of gene expression of the core self-renewal network of ESC. Further analysis of the AFCL gene expression profile suggests that AFCL, like XEN, have a high expression of Sall4 , Lin28, and Utf1 , which may be able to participate in an XEN-type self-renewal gene network. Importantly, previous studies described a critical role for Sall4 in XEN self-renewal [Lim et al., 2008] , giving support to the above hypothesis. However, additional studies will be required to test the dependence of AFCL self-renewal on Sall4 , Utf1, and/or Lin28 .
The majority of previously examined mouse XEN cell lines exhibit several characteristics of PE in culture [Kunath et al., 2005; Brown et al., 2010; Paca et al., 2012] . These include poor maintenance of epithelial appearance during extended culture and predominant contribution to PE after blastocyst injection, which is suggestive of their predominant PE differentiation potential. However, rat XEN cell lines appear to have a more balanced VE versus PE differentiation potential resulting in significant contribution of these cells to extraembryonic VE upon blastocyst injection [Debeb et al., 2009] and also in activation of the PE program with forskolin and the VE program with a small-molecule GSK3 inhibitor [Chuykin et al., 2013] . To examine the in vitro differentiation potency of AFCL, we began with an observation that AFCL grown on gelatin surface have growth characteristics similar to XEN, including ineffective maintenance of epithelial properties, which is consistent with the PE potential [Hogan and Tilly, 1981] . Furthermore, statistical analysis of the whole transcriptome profile of AFCL suggested that it correlates most closely with the profile of blastocystderived XEN cells and ExEn-like Pys2 cells, and this analysis showed that AFCL express transcripts of both PE and VE, suggestive of their bipotency. However, when we examined the gene expression profile of K82 cells cultured for 2-3 weeks after reaching confluence, using a qPCR array, we observed significant induction of Afp expression (data not shown), consistent with VE-type differentiation, as Afp is mainly expressed in VE and not PE [Dziadek and Adamson, 1978] . To confirm our hypothesis of the VE differentiation potential of AFCL, we tested several different cytokines and observed that BMP4 is critical for induction of AFP and ALB expression, suggesting that BMP4 can induce extraembryonic VE [Yasunaga et al., 2005] in AFCL, which is consistent with published reports describing BMP4-mediated VE induction in blastocyst-derived XEN [Artus et al., 2012; Paca et al., 2012] . Further analysis of in vitro Afp and Alb expression in all 3 AFCL, submitted to an abbreviated differentiation protocol, confirmed that they are capable of extraembryonic VE-type differentiation with somewhat different efficiencies. The molecular basis for these differences is not clear, but it may come from differential expression of a number of PE-and/or VE-specific genes, as evidenced from microarray analysis, and/or a difference in Gata6 expression (higher in K82), as observed during comparative qPCR analysis. Of note, the same experiment also shows that the basic AFCL maintenance medium can be used to propagate cells with a higher baseline expression level of Afp and Alb , suggesting that modest increase in the expression of VE-type markers does not interfere with cell line propagation. The elevated levels of Afp and Alb are likely related to a different lot of ESC-tested FBS used for routine maintenance of AFCL, as previous studies demonstrated the presence of BMP-type activity in FBS [Kodaira et al., 2006] as well as a significant lot-to-lot variability in BMP content of FBS [Herrera and Inman, 2009] . To examine the in vivo differentiation potential of AFCL, we analyzed the histological characteristics of AFCL-derived tumors and observed endodermal sinus-type glandular clusters that also showed presence of AFP, which can suggest a potentially significant in vivo VE differentiation potential of AFCL. However, further studies would be required to confirm this hypothesis because Afp may be expressed in tissues other than VE [Yasunaga et al., 2005] . In summary, AFCL appear to display a contextrelated VE or PE differentiation potential similar to previously studied blastocyst-derived XEN cell lines.
The origin of AFC capable of generating PrE cell lines in vitro is currently unknown. Such cell lines have mostly been generated from blastocyst-stage embryos in the past [Kunath et al., 2005] . However, a recent report also suggested that PrE cell lines can be generated from adult rat bone marrow [Roelandt et al., 2010] . AF may therefore receive PrE endoderm progenitors through a transient communication between amniotic and yolk sacs via a transient neurenteric canal [Ozek et al., 2008] . Alternatively, XEN cell lines may derive from PrE-derived cells in fetal gut [Kwon et al., 2008] , which are then released into AF through regular emptying of fetal gut contents, an activity observed in both early and mid-gestation human fetuses [Kimble et al., 1999] . A less likely possibility is transdifferentiation of definitive endodermal progenitors into XEN cell lines when maintained under the culture conditions described above
In this report, we describe the derivation of AFCL from AF of the 129X1/SvJ mouse strain. This strain was purposefully chosen as the initial donor of AF because of previous reports of high permissiveness for ESC derivation of the same mouse strain [Brook and Gardner, 1997] . XEN were initially derived from several different mouse strains, including PO, ICR and 129 [Kunath et al., 2005] , as well as from several different rat strains [Debeb et al., 2009] , without the use of small-molecule inhibitors, which were required for efficient derivation of ESC from various mouse and rat strains [Blair et al., 2011] . This suggests that AFCL could potentially be established from different mouse and rat strains with minimal protocol modification. Importantly, ExEn cell lines have not yet been established from human blastocysts. The information we have about human PrE lineage mostly comes from studies on PrE cells that arise during human ESC and iPSC differentiation [Takayama et al., 2011; Feng et al., 2012] . Interestingly, a recent report describes a population of c-KIT+ cells isolated from first-trimester human AF that express Sox7 [Moschidou et al., 2012] , a key factor in the development of PE. Whether these human AFC represent human counterparts of mouse AFCL-generating progenitors remains to be studied.
In summary, we have demonstrated that culture of AFderived progenitor cells in culture conditions that support self-renewal can generate phenotypically stable self-renewing cell lines of the PrE lineage. Our approach has an excellent reproducibility of cell line derivation and the phenotypic stability of AFCL. These findings, together with the previously published results that suggest the presence of lineage plasticity in cells of PrE, allowing it to contribute to embryonic tissue at different stages of development [Kwon et al., 2008; Grabarek et al., 2012] , would make potential human counterparts of such cell lines a candidate for banking and subsequent manipulation to prepare cell replacement therapies for regenerative medicine.
